Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-... by Hurvitz, Sara A, Dr, Andre, Fabrice, Prof, Jiang, Zefei, Prof, Shao, Zhimin, Prof, Mano, Max S, MD, Neciosup, Silvia P, MD, Tseng, Ling-Min, MD, Zhang, Qingyuan, Prof, Shen, Kunwei, Prof, Liu, Donggeng, Prof, Dreosti, Lydia M, Prof, Burris, Howard A, MD, Toi, Masakazu, Prof, Buyse, Marc E, Prof, Cabaribere, David, MSc, Lindsay, Mary-Ann, PhD, Rao, Shantha, PhD, Pacaud, Lida Bubuteishvili, MD, Taran, Tetiana, MD, Slamon, Dennis, Prof

Get full text

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial by Baselga, José, Dr, Bradbury, Ian, PhD, Eidtmann, Holger, MD, Di Cosimo, Serena, MD, de Azambuja, Evandro, MD, Aura, Claudia, MD, Gómez, Henry, MD, Dinh, Phuong, MD, Fauria, Karine, PhD, Van Dooren, Veerle, MSc, Aktan, Gursel, MD, Goldhirsch, Aron, MD, Chang, Tsai-Wang, MD, Horváth, Zsolt, MD, Coccia-Portugal, Maria, MD, Domont, Julien, MD, Tseng, Ling-Min, MD, Kunz, Georg, MD, Sohn, Joo Hyuk, MD, Semiglazov, Vladimir, MD, Lerzo, Guillermo, MD, Palacova, Marketa, MD, Probachai, Volodymyr, MD, Pusztai, Lajos, DPhil, Untch, Michael, PhD, Gelber, Richard D, PhD, Piccart-Gebhart, Martine, PhD

Get full text

SirT1--a sensor for monitoring self-renewal and aging process in retinal stem cells by Peng, Chi-Hsien, Chang, Yuh-Lih, Kao, Chung-Lan, Tseng, Ling-Ming, Wu, Chih-Chia, Chen, Yu-Chih, Tsai, Ching-Yao, Woung, Lin-Chung, Liu, Jorn-Hon, Chiou, Shih-Hwa, Chen, Shih-Jen

Get full text

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer by Lu, Yen-Shen, Chen, Dar-Ren, Tseng, Ling-Min, Yeh, Dah-Cherng, Chen, Shou-Tung, Hsieh, Chia-Ming, Wang, Hwei-Chung, Yeh, Hsien-Tang, Kuo, Sung-Hsin, Huang, Chiun-Sheng

Get full text

ErbB2-Mediated Src and Signal Transducer and Activator of Transcription 3 Activation Leads to Transcriptional Up-Regulation of p21Cip1 and Chemoresistance in Breast Cancer Cells by Hawthorne, Valerie S, Huang, Wen-Chien, Neal, Christopher L, Tseng, Ling-Min, Hung, Mien-Chie, Yu, Dihua

Get full text

Abstract 4465: Sequential combination of docetaxel with a novel SHP-1 agonist enhanced anti-tumor effect in triple negative breast cancer cells by Tseng, Ling-Min, Liu, Chun-Yu, Yang, Shiu-Ping, Wang, Wan-Lun, Su, Jung-Chen, Wu, Chia-Yun, Shiau, Chung-Wai, Chen, Kuen-Feng

Get full text

Abstract 2778: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells by Tseng, Ling-Min, Liu, Chun-Yu, Hsu, Chia-Jung, Wang, Duen-Shian, Su, Jung-Chen, Shiau, Chung-Wai, Chen, Kuen-Feng

Get full text

Abstract 914: CIP2A mediates the effect of tamoxifen-induced apoptosis in estrogen receptor negative breast cancer cells by Tseng, Ling-Min, Liu, Chun-Yu, Chang, Kung-Chi, Wang, Duen-Shian, Shiau, Chung-Wai, Chen, Kuen-Feng

Get full text

Abstract S6-01: Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women wi... by Hurvitz, Sara A, Andre, Fabrice, Jiang, Zefei, Shao, Zhimin, Neciosup, Silvia P, Mano, Max S, Tseng, Ling-Min, Zhang, Qingyuan, Shen, Kunwei, Liu, Donggeng, Dreosti, Lydia M, Feng, Jifeng, Burris, Howard A, Toi, Masakazu, Buyse, Marc E, Cabaribere, David, Lindsay, Mary-Ann, Kunz, Tiffany, Rao, Shantha, Pacaud, Lida B, Taran, Tetiana, Slamon, Dennis

Get full text

Abstract 2622: CIP2A mediates the apoptotic effect of bortezomib on triple negative breast cancer cells by Tseng, Ling-Min, Liu, Chun-Yu, Chang, Kung-Chi, Shiau, Chung-Wai, Cheng, Ann-Lii, Kuo, Hsin-Yu, Tzeng, Cheng-Hwai, Chen, Kuen-Feng

Get full text

ErbB2-mediated Src and STAT3 Activation Leads to Transcriptional Upregulation of p21Cip1 and Chemoresistance in Breast Cancer Cells by Hawthorne, Valerie S., Huang, Wen-Chien, Neal, Christopher L., Tseng, Ling-Min, Hung, Mien-Chie, Yu, Dihua

Get full text